These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27296649)

  • 1. Prostate cancer: TRIM24 acts as a transcriptional activator.
    Stone L
    Nat Rev Urol; 2016 Aug; 13(8):437. PubMed ID: 27296649
    [No Abstract]   [Full Text] [Related]  

  • 2. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
    Groner AC; Cato L; de Tribolet-Hardy J; Bernasocchi T; Janouskova H; Melchers D; Houtman R; Cato ACB; Tschopp P; Gu L; Corsinotti A; Zhong Q; Fankhauser C; Fritz C; Poyet C; Wagner U; Guo T; Aebersold R; Garraway LA; Wild PJ; Theurillat JP; Brown M
    Cancer Cell; 2016 Jun; 29(6):846-858. PubMed ID: 27238081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer.
    Höflmayer D; Fraune C; Hube-Magg C; Simon R; Schroeder C; Büscheck F; Möller K; Dum D; Weidemann S; Wittmer C; Schlomm T; Huland H; Heinzer H; Graefen M; Haese A; Sauter G; Burandt E; Clauditz TS; Steurer S; Minner S; Wilczak W; Polonski A
    Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):e29-e38. PubMed ID: 33491944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.
    Gross M; Liu B; Tan J; French FS; Carey M; Shuai K
    Oncogene; 2001 Jun; 20(29):3880-7. PubMed ID: 11439351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of castration-recurrent prostate cancer.
    Azzouni F; Mohler J
    Urol Clin North Am; 2012 Nov; 39(4):435-52. PubMed ID: 23084522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
    Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
    Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
    Lo SH; Lo TB
    Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and biological roles of TRIM24 in human bladder carcinoma.
    Xue D; Zhang X; Zhang X; Liu J; Li N; Liu C; Liu Y; Wang P
    Tumour Biol; 2015 Sep; 36(9):6849-55. PubMed ID: 25846736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer.
    Zhang J; Lu Y; Dai J; Yao Z; Kitazawa R; Kitazawa S; Zhao X; Hall DE; Pienta KJ; Keller ET
    Prostate; 2004 Jun; 59(4):360-9. PubMed ID: 15065084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells.
    Lee MY; Lu A; Gudas LJ
    J Cell Physiol; 2010 Jul; 224(1):17-27. PubMed ID: 20232320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Par-4 inducible apoptosis in prostate cancer cells.
    Gurumurthy S; Rangnekar VM
    J Cell Biochem; 2004 Feb; 91(3):504-12. PubMed ID: 14755681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the human gastrin-releasing peptide receptor gene in gastrointestinal and prostatic epithelial cancer cells.
    Qu X; Xiao D; Weber HC
    J Mol Neurosci; 2004; 22(1-2):75-82. PubMed ID: 14742912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
    Qiu G; Ahmed M; Sells SF; Mohiuddin M; Weinstein MH; Rangnekar VM
    Oncogene; 1999 Jan; 18(3):623-31. PubMed ID: 9989812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
    Zhang X; Wang L; Wang Y; Shi S; Zhu H; Xiao F; Yang J; Yang A; Hao X
    Oncol Rep; 2016 Oct; 36(4):2349-56. PubMed ID: 27573292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.